{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260615875061/en/U.S.-FDA-Accepts-Gilead%E2%80%99s-Application-for-Investigational-Once-Weekly-Oral-Yeztugo-Potentially-the-First-Long-Acting-Pill-for-HIV-Prevention", "message": "News view counter 800369 successfully enlarged"}